Insights
Search Results
Client Highlights
2.26.26
Wilson Sonsini Advises Eventus on Majority Investment by Terminus Capital Partners
On February 26, 2026, Terminus Capital Partners (TCP), a growth‑oriented private equity firm focused on majority investments in B2B software companies, and Eventus, a leading provider of comprehensive, at-scale trade surveillance and financial risk solutions, announced that TCP has acquired majority control in Eventus, positioning the firm for accelerated geographical expansion and growth in its product offerings. Wilson Sonsini Goodrich & Rosati advised Eventus on the transaction.
Client Highlights
2.12.26
Wilson Sonsini Advises Delta40 on $20 Million Funding
On February 11, 2026, Delta40, an integrated venture studio and VC fund investing in and supporting founders on the frontlines of Africa’s most urgent challenges, announced $20 million in funding. The milestone marks Africa’s first institutional raise linking venture building and early-stage capital, merging investment with hands-on studio support from experienced operators to build and scale start-ups across the continent. Wilson Sonsini Goodrich & Rosati advised Delta40 on the transaction.
Delta40 initially launched its venture studio model in Kenya and has since expanded to Lagos, Nigeria, providing portfolio companies with direct, on-the-ground support as they scale across the continent. Delta40 pioneered a unique venture studio and fund model that combines early-stage capital with embedded product, fundraising, commercial, finance, legal, growth, and exit expertise. Through this model, Delta40 partners with founders from idea to scale across energy and mobility, agriculture, and fintech—with a goal to integrate AI across all sectors.
Delta40 initially launched its venture studio model in Kenya and has since expanded to Lagos, Nigeria, providing portfolio companies with direct, on-the-ground support as they scale across the continent. Delta40 pioneered a unique venture studio and fund model that combines early-stage capital with embedded product, fundraising, commercial, finance, legal, growth, and exit expertise. Through this model, Delta40 partners with founders from idea to scale across energy and mobility, agriculture, and fintech—with a goal to integrate AI across all sectors.
Client Highlights
12.17.25
Wilson Sonsini Advises Hexagon Bio on Multimillion-Dollar Joint Venture with Corteva
On December 16, 2025, Corteva, a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, announced a multimillion-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva. Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the transaction.
The partnership brings together Corteva’s billion-dollar nature-inspired crop protection franchises and bacterial natural product discovery capabilities with Hexagon Bio’s natural-product discovery platform to advance the companies’ respective pipelines across agriculture and human health. Hexagon Bio’s platform combines microbial genetics, artificial intelligence, chemistry, and synthetic biology to identify and characterize novel natural products, uncovering diverse mechanisms not obvious from the chemical structure or conventional techniques and allowing for more efficient molecule discovery.
The Wilson Sonsini team that advised Hexagon Bio on the transaction included Ken Clark, Norm Hovijitra, Aleks Vitomirov, Lance Brady, Christina Poulsen, Adrian Broderick, Sara Pollock, Jacob Morales, Henry Yen, Myra Sutanto Shen, and Rob Sherrill.
For more information, please see the companies’ joint news release.
The partnership brings together Corteva’s billion-dollar nature-inspired crop protection franchises and bacterial natural product discovery capabilities with Hexagon Bio’s natural-product discovery platform to advance the companies’ respective pipelines across agriculture and human health. Hexagon Bio’s platform combines microbial genetics, artificial intelligence, chemistry, and synthetic biology to identify and characterize novel natural products, uncovering diverse mechanisms not obvious from the chemical structure or conventional techniques and allowing for more efficient molecule discovery.
The Wilson Sonsini team that advised Hexagon Bio on the transaction included Ken Clark, Norm Hovijitra, Aleks Vitomirov, Lance Brady, Christina Poulsen, Adrian Broderick, Sara Pollock, Jacob Morales, Henry Yen, Myra Sutanto Shen, and Rob Sherrill.
For more information, please see the companies’ joint news release.
Client Highlights
7.09.25
Wilson Sonsini Advises Jony Ive and LoveFrom on $6.5 Billion Acquisition of io Products by OpenAI
On July 9, 2025, OpenAI closed its acquisition of io Products, a hardware start-up company co-founded by Jony Ive, for approximately $6.5 billion in stock. Jony Ive and his design firm, LoveFrom, will remain independent and assume deep design and creative responsibilities across OpenAI. Wilson Sonsini advised Jony Ive and LoveFrom on the transaction.
Client Highlights
12.23.24
Wilson Sonsini Advises USANA Health Sciences on Acquisition of Hiya Health
On December 23, 2024, USANA Health Sciences announced the acquisition of a 78.8 percent controlling ownership stake in Hiya Health Products, a leading direct-to-consumer provider of high-quality children’s health and wellness products. The $205 million cash transaction was completed on the same date and is anticipated to be accretive to USANA’s 2025 adjusted EBITDA. Wilson Sonsini Goodrich & Rosati advised USANA on the transaction.
Client Highlights
10.01.24
Wilson Sonsini Advises PayRange on Investment by Ridgeview Partners
On September 30, 2024, Ridgeview Partners, in partnership with The Baupost Group, announced it has agreed to make a significant strategic growth investment in PayRange, a leading provider of IOT software and payment solutions for unattended retail. Wilson Sonsini Goodrich & Rosati advised PayRange on the transaction.
Client Highlights
7.08.24
Firm Advises Sunrun on over $1 Billion in Non-Recourse Financings in Q2 2024, Including Record-Setting Securitization
On June 11, 2024, Sunrun, the nation’s leading home solar, battery storage, and energy services company, completed its latest asset-backed securitization of solar leases and power purchase agreements. The securitization consists of $886.3 million in A+ rated Class A-1 and Class A-2 notes and $91.2 million in BB rated Class B notes, for an aggregate $977.5 million initial balance. The notes are secured by two tax equity funds of rooftop solar and energy storage systems distributed across various states and utility service territories. ATLAS SP Securities, a division of Apollo Global Securities, LLC, acted as structuring agent and served as joint bookrunner along with Citigroup Global Markets Inc., J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., and RBC Capital Markets, LLC as co-managers and initial purchasers for the securitization, and SMBC Nikko Securities America, Inc. as an initial purchaser. The $443.15 million Class A-1 notes were publicly marketed and the $443.15 million Class A-2 notes were privately placed. At closing, the asset-backed securitization was both the largest ever in Sunrun’s history and across the entire residential solar industry. Combined with a $230 million asset-backed securitization of solar leases and power purchase agreements closed in April 2024, the Class A-1 and Class A-2 notes collectively represent over $1 billion of senior debt financing raised by Sunrun in the second fiscal quarter of 2024.
Client Highlights
11.02.23
Firm Advises Sunrun on over $1 Billion in Non-Recourse Financings in Third Quarter of 2023, including Record-Setting Securitization
On September 26, 2023, Sunrun, the nation’s leading home solar, battery storage, and energy services company, completed its latest asset-backed securitization of solar leases and power purchase agreements. The securitization consists of $715 million in A- rated Class A-1 and Class A-2 notes and $80 million in BB+ rated Class B notes for an aggregate $795 million initial balance. The notes are secured by tax-equity and wholly-owned funds of rooftop solar and energy storage systems distributed across various states and utility service territories. Deutsche Bank acted as the sole structuring agent and served as joint bookrunner along with ATLAS SP Securities, BofA Securities, and MUFG Securities Americas, with Credit Agricole Securities, Citigroup Global Markets, ING Financial Markets, J.P. Morgan Securities LLC, SG Americas Securities, TD Securities, and Truist Securities as co-managers for the securitization. The $440 million Class A-1 notes were publicly marketed and the $275 million Class A-2 notes were privately placed. At closing, the asset-backed securitization was both the largest ever in Sunrun’s history and across the entire residential solar industry. Combined with a senior portfolio term-out financing closed in July 2023, the Class A-1 and Class A-2 notes collectively represent over $1 billion of senior term debt financing raised by Sunrun in the third fiscal quarter of 2023.
Client Highlights
8.02.23
Wilson Sonsini Advises Boyu Capital on Quasar Medical Acquisition
On July 31, 2023, The Longreach Group announced that it had, together with the founder family minority shareholders, completed the sale of all the issued and outstanding shares in Quasar Medical to funds managed by Boyu Capital. The deal value was not disclosed. Wilson Sonsini Goodrich & Rosati represented Boyu Capital in this acquisition.
Client Highlights
7.08.22
Wilson Sonsini Advises Matchwell on Its Acquisition by Medical Solutions
On July 6, 2022, Medical Solutions, one of the nation's largest providers of total workforce solutions serving the healthcare industry, announced it has acquired Durhan, North Carolina-based Matchwell. Matchwell’s AI enabled marketplace and SaaS solution efficiently matches licensed and certified staff with healthcare organizations across a variety of clinical settings ranging from hospitals to skilled and assisted living facilities, home health, clinics, and schools. Matchwell’s business model of subscription-based, per diem, and local services expands Medical Solutions’ current portfolio of service offerings into the per diem and local markets and further bolsters the company’s total workforce solutions model. Terms of the deal were not disclosed.
Client Highlights
10.14.21
Wilson Sonsini Represents Track 1099 in Its Acquisition by Avalara
On October 1, 2021, Avalara, a leading provider of tax compliance automation software for businesses of all sizes, announced it has acquired Track1099 LLC, a company that provides online software and services for cost-effectively managing, e-filing, and e-delivering IRS forms, including 1099s, W-2s, W-9s, and more. Wilson Sonsini Goodrich & Rosati represented Track1099 in the transaction.
Client Highlights
7.29.21
Wilson Sonsini Advises Epic on Its $500 Million Acquisition By BYJU’S
On July 21, 2021, the global leader in personalized online learning, BYJU’s (backed by General Atlantic, Sequoia Capital, the Chan-Zuckerberg Initiative, Naspers, Silver Lake, Tiger Global, and other notable investors), announced a $500 million acquisition of Epic, the world’s leading digital reading platform for kids 12 and under. The acquisition will help expand BYJU’S U.S. footprint by providing access to the more than two million teachers and 50 million kids in Epic’s existing global user base, which more than doubled over the last year. Wilson Sonsini Goodrich & Rosati represented Epic in the transaction.